Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Immunogen reported $626K in Cost of Sales for its fiscal quarter ending in March of 2023.

Cost Of Sales Change
AbbVie ABBV:US USD 3.97B 200M
Agios Pharmaceuticals AGIO:US USD 554K 141K
Amgen AMGN:US USD 1.68B 65M
Astellas Pharma 4503:JP JPY 62.28B 12.14B
AstraZeneca AZN:LN USD 2.05B 458M
Bluebird Bio BLUE:US USD 3.38M 3.36M
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Eli Lilly LLY:US USD 1.63B 78.6M
Emergent BioSolutions EBS:US USD 155.1M 64.3M
Exelixis EXEL:US USD 14.32M 1.6M
Halozyme Therapeutics HALO:US USD 35.17M 6.95M
Heron Therapeutics HRTX:US USD 16.85M 4.23M
Immunogen IMGN:US USD 626K 450K
Karyopharm Therapeutics KPTI:US USD 1.35M 517K
MacroGenics MGNX:US USD 3.52M 1.73M
Nektar Therapeutics NKTR:US USD 7.06M 827K
Novartis NVS:US USD 3.83B 8M
Pfizer PFE:US USD 5.03B 4.8B
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Roche Holding ROG:VX CHF 8.95B 613M
Seattle Genetics SGEN:US USD 111.78M 3.57M